Sugi Predict

Sugi Predict / Compounds / SCHEMBL12847481

SCHEMBL12847481

SCHEMBL12847481

CNCCNCCC(=O)OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.52
▸ CA12 O43570 4/20 0.48
▸ CA14 Q9ULX7 4/20 0.48
▸ LTA4H P09960 1/20 0.44
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CA7 P43166 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ LMNA P02545 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CA2 P00918 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ MGAM O43451 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ SI P14410 1/20 0.37
▸ MGAM2 Q2M2H8 1/20 0.37
▸ EPHX2 P34913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12847508 0.91 TSHR (0.63) TSHRCA12CA14LTA4HKMT2A
SCHEMBL10042464 0.91 TSHR (0.63) TSHRCA12CA14LTA4HKMT2A
SCHEMBL72889 0.88 TSHR (0.67) TSHRCA12CA14LTA4HKMT2A
SCHEMBL10038847 0.87 TSHR (0.50) TSHRCA12CA14LTA4HKMT2A
SCHEMBL10038845 0.87 TSHR (0.50) TSHRCA12CA14LTA4HKMT2A
SCHEMBL941004 0.85 — —
Hydrochloric Acid SCHEMBL380895 0.83 — —
SCHEMBL16638641 0.82 TSHR (0.52) TSHRCA12CA14LTA4HKMT2A
SCHEMBL12847703 0.82 TSHR (0.52) TSHRCA12CA14LTA4HKMT2A
SCHEMBL29915714 0.81 TSHR (0.59) TSHRCA12CA14LTA4HKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023070947-A1 HYPERBRANCHED MODIFIED NANO-MATERIAL AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN HEAVY OIL VISCOSITY REDUCER 宁波锋成先进能源材料研究院有限公司 2023-05-04 — — WO disclosed
US-20160009657-A1 AMINE-CONTAINING LIPIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-01-14 — — US disclosed
US-9006487-B2 Amine-containing lipids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-04-14 — — US disclosed
US-20110052673-A1 THERAPEUTIC COMPOSITIONS SHIRE HUMAN GENETIC THERAPIES, INC. 2011-03-03 — — US disclosed
US-20110009641-A1 Amine-containing lipids and uses thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-01-13 — — US disclosed
EP-1905829-A2 Templated molecules and methods for using such molecules Nuevolution A/S (DK) 2008-04-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110052673-A1 THERAPEUTIC COMPOSITIONS PHOSPHO1, SGMS1, APOB TSHR 2608/4885CA12 1652/4885CA14 1791/4885
US-20110009641-A1 Amine-containing lipids and uses thereof PHOSPHO1, CHMP4B, SGMS1 TSHR 4001/4885CA12 4058/4885CA14 3642/4885
US-20160009657-A1 AMINE-CONTAINING LIPIDS AND USES THEREOF PHOSPHO1, CHMP4B, SGMS1 TSHR 4001/4885CA12 4058/4885CA14 3642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.